Microbial and Phage Cultivation Core

微生物和噬菌体培养核心

基本信息

  • 批准号:
    10583460
  • 负责人:
  • 金额:
    $ 38.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-01 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The overall goal of the BCM-CARBIRU is to explore non-antibiotic therapeutic approaches to combating antibiotic resistant bacterial pathogens that are deemed urgent and serious threats. To meet this goal, the establishment of the Microbial and Phage Cultivation (MPC) core will provide to the projects the ability to cultivate bacteria and phage in multiple formats and under different atmospheric conditions. The core will also provide sequencing support of newly identified bacteria and phage that emerge from each of the three projects. The MPC organized around three primary objectives. Objective 1. Cultivation of complex microbial communities and individual microbes. Objective 2. Isolation and optimization of bacteriophage for AMR pathogens. Objective 3. Sequencing of individual microbes, phage and complex microbial communities. Centralization of these objectives into the MPC core will reduce costs by allowing all of the projects access to the infrastructure (such as anaerobic and microoxic chambers), bulk purchasing of reagents, and the reduction in labor costs by having dedicated technicians to assist in generation of bacteria and phage. The MPC will facilitate the transfer of expertise in microbial and phage cultivation from the core to trainees from all three projects. Finally, a centralized resource for sequencing of bacteria and phage will allow more coordination between the projects in regard to genomic analysis and data integration. The MPC will be an essential part of the BCM-CARBIRU that, along with the Organoid Cultivation Core, will help achieve the overall goals proposed.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT A BRITTON其他文献

ROBERT A BRITTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT A BRITTON', 18)}}的其他基金

Multi-method investigation and characterization of the ocular microbiome
眼部微生物组的多方法研究和表征
  • 批准号:
    10660691
  • 财政年份:
    2023
  • 资助金额:
    $ 38.24万
  • 项目类别:
Engineered probiotic for the treatment of autoimmune diseases
用于治疗自身免疫性疾病的工程益生菌
  • 批准号:
    10561101
  • 财政年份:
    2023
  • 资助金额:
    $ 38.24万
  • 项目类别:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
定义微生物群落以预防和根除 AMR 病原体感染
  • 批准号:
    10357969
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Admin Core - Britton
管理核心 - 布里顿
  • 批准号:
    10583458
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
微生物组的发现和对抗粘膜表面抗生素耐药性的机制
  • 批准号:
    10357964
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Microbial and Phage Cultivation Core
微生物和噬菌体培养核心
  • 批准号:
    10357966
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Admin Core - Britton
管理核心 - 布里顿
  • 批准号:
    10357965
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
微生物组的发现和对抗粘膜表面抗生素耐药性的机制
  • 批准号:
    10583457
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
定义微生物群落以预防和根除 AMR 病原体感染
  • 批准号:
    10583468
  • 财政年份:
    2021
  • 资助金额:
    $ 38.24万
  • 项目类别:
Diet driven evolution of epidemic ribotypes of Clostridium difficile
饮食驱动艰难梭菌流行性核糖型的进化
  • 批准号:
    10053311
  • 财政年份:
    2017
  • 资助金额:
    $ 38.24万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 38.24万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 38.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了